FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine, specifically to ophthalmology, and is intended for the treatment of eye injury. For the treatment of eye injury, which is selected from the group consisting of post-surgical inflammation, postoperative fibrosis, corneal injury, a cataract incision, laser-assisted in situ keratomileusis (LASIK) wounds and a photorefractive keratectomy (PRK) wound, the subject is administered an effective amount of an angiotensin peptide containing Nle3-A (1–7) (SEQ ID NO: 14). Also provided is a pharmaceutical composition for topical treatment of eye injury comprising (a) an angiotensin peptide comprising Nle3-A (1–7) (SEQ ID NO: 14), (b) an active agent selected from the group consisting of artificial tears thereof, and (c) a pharmaceutically acceptable carrier.
EFFECT: use of a group of inventions allows to reduce the duration of edema and inflammation, as well as to increase the strength of healing and restore the transparency of the cornea of the eye.
26 cl, 2 dwg, 2 tbl, 2 ex
Title |
Year |
Author |
Number |
RECOMBINANT MODIFIED FIBROBLAST GROWTH FACTORS AND THEIR THERAPEUTIC USE |
2018 |
- Evelet, Devid
- Dzhenkins-Evelet, Dzhennifer
- Subramaniam, Amutakannan
- Bredshou, Ralf
|
RU2811435C2 |
PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING EYE DISEASES, CONTAINING, AS ACTIVE INGREDIENT, FUSION PROTEIN IN WHICH TISSUE-PENETRATING PEPTIDE AND ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR PREPARATION ARE FUSED |
2016 |
- Kim, Seong Beom
- Jung, Hyei Yoon
- Yang, Seok Woo
- Kwon, Hyuk Sang
- Kang, Jae-Hoon
|
RU2712623C2 |
PRODRUG COMPOSITIONS WITH HIGH DEGREE OF PENETRATION BASED ON PEPTIDES AND RELATED COMPOUNDS |
2010 |
- Yuj Chunsi
- Syuj Lina
- Chen Yujkhua
- Yan Binbin
- Tu Shitsyan
|
RU2627065C2 |
ALPHA- AND GAMMA-MSH ANALOGUES |
2013 |
|
RU2668791C2 |
TREATMENT OF MUSCULAR WEAKNESS WITH ALKALINE PHOSPHATASES |
2017 |
|
RU2754558C2 |
PHARMACEUTICAL COMPOSITIONS CONTAINING PEPTIDE VERSIONS, AND METHODS OF USING THEM |
2015 |
- Lindhout, Darrin, Anthony
- Olson, Charles, V.
|
RU2729161C2 |
GREMLIN-1 INHIBITOR FOR THE TREATMENT OF BONE FRACTURE OR BONE DEFECT |
2019 |
- Davies, Gareth Charles Glyndwr
- Roberts, Scott John
|
RU2790992C2 |
SELECTION OF PATIENTS WITH HEADACHE SUSCEPTIBLE TO ANTIBODIES AGAINST CALCITONIN GENE-RELATED PEPTIDE |
2018 |
|
RU2770066C2 |
PROTEIN BINDING WITH NKG2D, CD16 AND WITH TUMOR-SPECIFIC ANTIGEN |
2018 |
- Chang, Gregory P.
- Cheung, Ann F.
- Haney, William
- Lunde, Bradley M.
- Prinz, Bianka
|
RU2788531C2 |
ANTIBODIES AGAINST ANG-2 CONTAINING ONLY HEAVY CHAIN |
2016 |
- Liang Yanbin
- Gil Daniel W.
|
RU2749674C2 |